Recall Record

Canton, MA, United States

Fresenius Kabi Compounding, LLC recalls

2 recalls recorded since 2018, most recently on 5 February 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)1
Terminated or completed1
Class I (FDA)0

Ongoing Class II Drugs

Recall started
5 February 2026
Reason
Lack of Assurance of Sterility
Distribution
US Nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0335-2026, D-0334-2026, D-0336-2026, D-0337-2026, D-0333-2026

Terminated Class II Drugs

Recall started
25 September 2024
Terminated
15 August 2025
Reason
cGMP violations
Distribution
Product was distributed to 125 direct accounts nationwide.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0020-2025, D-0016-2025, D-0022-2025, D-0021-2025, D-0019-2025, D-0015-2025, D-0023-2025, D-0018-2025, D-0014-2025, D-0017-2025

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.